complementary medicine for Parkinson's (NCT07207096)
Complementary medicine to reduce stiffness
- Trial ID
- NCT07207096
- Official Title
- Observational Case Series of Patients With Parkinson's Disease (PD) Attending a Complementary Medicine Neuro-degenerative Disease (NDD) Clinic.
- Goal
- Complementary medicine to reduce stiffness
- Status
- RECRUITING
- Sponsor
- St. Mary's University, Twickenham
- Study Type
- OBSERVATIONAL
- Enrollment
- 100 participants
- Conditions
- Parkinson Disease, Parkinsonism
- Interventions
- complementary medicine
Summary For Families
The goal is to track how people with Parkinson's disease or Parkinsonism do when they attend a complementary medicine neurodegenerative clinic, looking at symptom changes, safety, and quality of life over time. The approach is observational, recording which complementary therapies are used, for example tailored lifestyle and rehabilitation plans, acupuncture or other manual therapies, nutritional or herbal supplements, and mind-body approaches, and measuring how those treatments affect mobility, sleep, mood, pain and medication side effects; these therapies are provided alongside standard drugs like levodopa rather than replacing them, and the study will note any interactions or safety signals. Eligibility is adults 18 and older with a self-reported diagnosis of Parkinson's disease or Parkinsonism, excluding people who need acute medical care or who have another neurodegenerative diagnosis, and excluding those without a PD/Parkinsonism diagnosis even if they are at risk.
Locations
- Feldy Community Centre, London, United Kingdom
Frequently Asked Questions
- What is this trial testing?
- This trial is studying complementary medicine. The goal is to track how people with Parkinson's disease or Parkinsonism do when they attend a complementary medicine neurodegenerative clinic, looking at symptom changes, safety, and quality of life over time. The approach is observational, recording which complementary therapies are used, for example tailored lifestyle and rehabilitation plans, acupuncture or other manual therapies, nutritional or herbal supplements, and mind-body approaches, and measuring how those treatments affect mobility, sleep, mood, pain and medication side effects; these therapies are provided alongside standard drugs like levodopa rather than replacing them, and the study will note any interactions or safety signals. Eligibility is adults 18 and older with a self-reported diagnosis of Parkinson's disease or Parkinsonism, excluding people who need acute medical care or who have another neurodegenerative diagnosis, and excluding those without a PD/Parkinsonism diagnosis even if they are at risk.
- Who can participate?
- Participants must be at least 18 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 11 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.
- How many visits does this trial involve?
- Consultations take place approximately every 3 months, but the time between appointments may be reduced to 1 month or extended to 6 months.
- What procedures are involved in this trial?
- Based on the protocol, this trial involves: Questionnaires & surveys (non-invasive). Confirm the full schedule with the study coordinator.